FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety ...

On Tuesday, Bernstein released a report detailing the complexities of tariff risks within the biopharma sector and its potential impact on major companies. The analysis aims to unravel the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Trump ad­min­is­tra­tion’s threat­ened tar­iffs on Eu­rope would be painful for the biotech in­dus­try, ac­cord­ing to da­ta from a sur­vey con­duct­ed by the in­dus­try’s ...

BERLIN, Germany and BEIJING, China I March 26, 2025 I Bayer and Suzhou Puhe BioPharma Co.,Ltd., a clinical-stage biotechnology company, today announced that they have entered into a global license ...

Bayer (BAYGn.DE), opens new tab said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe BioPharma. Bayer, which did not ...

Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...

Ireland’s success in attracting biopharma investment dates back to the 1960s. Decades of strategic policymaking, a skilled workforce and a pro-business environment have made the State a hub for ...

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. Medical ...

The investment landscape for biotech and biopharma has been dry in recent years. Image credit: Shutterstock / rudall30. It’s widely known in the industry that private investment in biotech and ...

Billion-dollar biotech buyouts have become rarer. Only six of the acquisitions tracked by BioPharma Dive since July have met that mark, compared to 24 deals in the preceding nine-month period.